61 results
8-K
EX-99.1
APRE
Aprea Therapeutics Inc
26 Mar 24
Aprea Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Business Update
8:15am
, and highlighted the addressable unmet clinical need and potential combination therapies using these programs. A replay of the event can be access
8-K
EX-10.1
APRE
Aprea Therapeutics Inc
12 Mar 24
Aprea Therapeutics Announces Private Placement Financing of up to $34.0 Million
4:31pm
with applicable securities laws and GAAP and to maintain asset accountability, (iii) access to assets is permitted only in accordance with management’s general … and security of IT Systems and Data and to the protection of such IT Systems and Data from unauthorized use, access, misappropriation or modification
8-K
EX-10.2
i9h96ix0ckk hdlxnp3t
12 Mar 24
Aprea Therapeutics Announces Private Placement Financing of up to $34.0 Million
4:31pm
8-K
EX-99.1
ueifw1a
4 Jan 24
Aprea Therapeutics Provides Corporate Update and Announces Development Plans for 2024
4:16pm